Showing results (121-130 of 141) with videos related to
Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2013
Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cellsRekha Samuel, Laurence Daheron, Shan Liao, et al.Proceedings of the National Academy of Sciences of the United States of America|January 28, 2015
Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule deliveryMeenal Datta, Laura E Via, Walid S Kamoun, et al.Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
Quantum dot/antibody conjugates for in vivo cytometric imaging in miceHee-Sun Han, Elisabeth Niemeyer, Yuhui Huang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in miceWalid S Kamoun, Carsten D Ley, Christian T Farrar, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2019
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironmentNancy Dumont, Samantha Merrigan, Jason Turpin, et al.Journal of Occupational and Environmental Hygiene|December 4, 2024
Prevalence of interdigital pilonidal sinus in hair professionals during the COVID-19 pandemic: A cross-sectional studyHamdi Al Shenawi, Suhair Al Saad, Noor Al Shenawi, et al.Molecular Cancer Therapeutics|October 11, 2019
Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor ModelsWalid S Kamoun, Anne-Sophie Dugast, James J Suchy, et al.Birth Defects Research|May 27, 2023
Harmonization of criteria and terminology in fetal rat skeletal evaluationsL M Posobiec, C Kopp, S M Murzyn, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapyYuhui Huang, Jianping Yuan, Elda Righi, et al.Cancer Research|January 5, 2011
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escapeEmmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, et al.Pageof 15